Proactive high-dose IV iron is preferred therapy in ESKD patients: COMMENTARY
-
Published:2021-08-06
Issue:
Volume:
Page:10.34067/KID.0004892021
-
ISSN:2641-7650
-
Container-title:Kidney360
-
language:en
-
Short-container-title:Kidney360
Abstract
This is an Early Access article. Please select the PDF button, above, to view it.
Be sure to also read the PRO: 10.34067/KID.0002442021 and the CON: 10.34067/KID.0007152020
Publisher
American Society of Nephrology (ASN)